NASDAQ:ECOR

electroCore News Headlines

$1.79
+0.03 (+1.70 %)
(As of 04/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.57
Now: $1.79
$1.82
50-Day Range
$1.76
MA: $2.10
$2.64
52-Week Range
$0.77
Now: $1.79
$3.63
Volume1.16 million shs
Average Volume3.86 million shs
Market Capitalization$86.77 million
P/E RatioN/A
Dividend YieldN/A
Beta1.62

Headlines

electroCore (NASDAQ ECOR) News Headlines Today

SourceHeadline
Short Interest in electroCore, Inc. (NASDAQ:ECOR) Declines By 40.5%Short Interest in electroCore, Inc. (NASDAQ:ECOR) Declines By 40.5%
americanbankingnews.com - April 17 at 2:08 AM
Is electroCore (NASDAQ:ECOR) Using Too Much Debt? - NasdaqIs electroCore (NASDAQ:ECOR) Using Too Much Debt? - Nasdaq
nasdaq.com - April 15 at 9:37 AM
electroCore Announces Publication in Nature Reviews: Neurology Highlighting the Role of Non-Invasive Vagus Nerve Stimulation (nVNS) as an Emerging Treatment for Cluster Headache - GlobeNewswireelectroCore Announces Publication in Nature Reviews: Neurology Highlighting the Role of Non-Invasive Vagus Nerve Stimulation (nVNS) as an Emerging Treatment for Cluster Headache - GlobeNewswire
globenewswire.com - April 15 at 9:37 AM
electroCore Announces Publication in Nature Reviews: Neurology Highlighting the Role of Non-Invasive Vagus Nerve Stimulation (nVNS) as an Emerging Treatment for Cluster HeadacheelectroCore Announces Publication in Nature Reviews: Neurology Highlighting the Role of Non-Invasive Vagus Nerve Stimulation (nVNS) as an Emerging Treatment for Cluster Headache
finance.yahoo.com - April 15 at 9:37 AM
electroCore Provides Business Update and Select First Quarter 2021 Financial Guidance - GlobeNewswireelectroCore Provides Business Update and Select First Quarter 2021 Financial Guidance - GlobeNewswire
globenewswire.com - April 13 at 8:33 AM
electroCore Provides Business Update and Select First Quarter 2021 Financial GuidanceelectroCore Provides Business Update and Select First Quarter 2021 Financial Guidance
finance.yahoo.com - April 13 at 8:33 AM
electroCore Announces Top Line Results from SAVIOR-1 study of Non-Invasive Vagus Nerve Stimulation (nVNS) in Hospitalized COVID-19 Patients - Yahoo FinanceelectroCore Announces Top Line Results from SAVIOR-1 study of Non-Invasive Vagus Nerve Stimulation (nVNS) in Hospitalized COVID-19 Patients - Yahoo Finance
finance.yahoo.com - April 10 at 9:44 AM
Critical Contrast: electroCore (NASDAQ:ECOR) versus Outset Medical (NASDAQ:OM)Critical Contrast: electroCore (NASDAQ:ECOR) versus Outset Medical (NASDAQ:OM)
americanbankingnews.com - April 9 at 12:20 PM
ElectroCores Stock Is Trading Higher As nVNS Decreases Certain COVID-19-Associated Biomarkers - Yahoo FinanceElectroCore's Stock Is Trading Higher As nVNS Decreases Certain COVID-19-Associated Biomarkers - Yahoo Finance
finance.yahoo.com - April 9 at 7:50 AM
electroCore shares rise after early-stage COVID-19 study topline data - Seeking AlphaelectroCore shares rise after early-stage COVID-19 study topline data - Seeking Alpha
seekingalpha.com - April 8 at 2:52 PM
ElectroCores Stock Is Trading Higher As nVNS Decreases Certain COVID-19-Associated BiomarkersElectroCore's Stock Is Trading Higher As nVNS Decreases Certain COVID-19-Associated Biomarkers
finance.yahoo.com - April 8 at 2:52 PM
electroCore (ECOR) Announces Top Line Results from SAVIOR-1 study of Non-Invasive Vagus Nerve Stimulation (nVNS) in Hospitalized COVID-19 Patients - StreetInsider.comelectroCore (ECOR) Announces Top Line Results from SAVIOR-1 study of Non-Invasive Vagus Nerve Stimulation (nVNS) in Hospitalized COVID-19 Patients - StreetInsider.com
streetinsider.com - April 8 at 9:51 AM
electroCore Announces Top Line Results from SAVIOR-1 study of Non-Invasive Vagus Nerve Stimulation (nVNS) in Hospitalized COVID-19 Patients - GlobeNewswireelectroCore Announces Top Line Results from SAVIOR-1 study of Non-Invasive Vagus Nerve Stimulation (nVNS) in Hospitalized COVID-19 Patients - GlobeNewswire
globenewswire.com - April 8 at 9:51 AM
electroCore Announces Top Line Results from SAVIOR-1 study of Non-Invasive Vagus Nerve Stimulation (nVNS) in Hospitalized COVID-19 PatientselectroCore Announces Top Line Results from SAVIOR-1 study of Non-Invasive Vagus Nerve Stimulation (nVNS) in Hospitalized COVID-19 Patients
finance.yahoo.com - April 8 at 9:51 AM
electroCore, Inc. (NASDAQ:ECOR) Given Consensus Recommendation of "Buy" by BrokerageselectroCore, Inc. (NASDAQ:ECOR) Given Consensus Recommendation of "Buy" by Brokerages
americanbankingnews.com - April 7 at 6:10 AM
electroCore (ECOR) announces Health Canada has granted regulatory approval for promotion and sale of the gammaCore Sapphire family of products - StreetInsider.comelectroCore (ECOR) announces Health Canada has granted regulatory approval for promotion and sale of the gammaCore Sapphire family of products - StreetInsider.com
streetinsider.com - April 7 at 12:28 AM
ElectroCores Stock Is Trading Higher After Its Nerve Stimulator Wins Canadian Approval For Migraine - Yahoo FinanceElectroCore's Stock Is Trading Higher After Its Nerve Stimulator Wins Canadian Approval For Migraine - Yahoo Finance
finance.yahoo.com - April 7 at 12:28 AM
electroCore, Inc. Announces Regulatory Approval in Canada - Yahoo FinanceelectroCore, Inc. Announces Regulatory Approval in Canada - Yahoo Finance
finance.yahoo.com - April 7 at 12:28 AM
ElectroCores Stock Is Trading Higher After Its Nerve Stimulator Wins Canadian Approval For Migraine - BenzingaElectroCore's Stock Is Trading Higher After Its Nerve Stimulator Wins Canadian Approval For Migraine - Benzinga
benzinga.com - April 5 at 6:15 PM
electroCore, Inc. Announces Regulatory Approval in Canada - GlobeNewswireelectroCore, Inc. Announces Regulatory Approval in Canada - GlobeNewswire
globenewswire.com - April 5 at 1:15 PM
ElectroCores Stock Is Trading Higher After Its Nerve Stimulator Wins Canadian Approval For MigraineElectroCore's Stock Is Trading Higher After Its Nerve Stimulator Wins Canadian Approval For Migraine
finance.yahoo.com - April 5 at 1:15 PM
electroCore, Inc. Announces Regulatory Approval in CanadaelectroCore, Inc. Announces Regulatory Approval in Canada
finance.yahoo.com - April 5 at 8:14 AM
electroCore, Inc. (NASDAQ:ECOR) Short Interest UpdateelectroCore, Inc. (NASDAQ:ECOR) Short Interest Update
americanbankingnews.com - March 29 at 3:18 PM
electroCore, Inc. Announces Exclusive Distribution Agreement with Silvert Medical Nv-Sa. For Western Europe - Yahoo FinanceelectroCore, Inc. Announces Exclusive Distribution Agreement with Silvert Medical Nv-Sa. For Western Europe - Yahoo Finance
finance.yahoo.com - March 25 at 7:36 AM
electroCore climbs on distribution deal for headache relief device in Europe - Seeking AlphaelectroCore climbs on distribution deal for headache relief device in Europe - Seeking Alpha
seekingalpha.com - March 24 at 10:45 AM
ECOR: More Distribution Agreements to Come - Yahoo FinanceECOR: More Distribution Agreements to Come - Yahoo Finance
finance.yahoo.com - March 23 at 6:34 PM
electroCore (ECOR) Announces Exclusive Distribution Agreement with Silvert Medical Nv-Sa. For Western Europe - StreetInsider.comelectroCore (ECOR) Announces Exclusive Distribution Agreement with Silvert Medical Nv-Sa. For Western Europe - StreetInsider.com
streetinsider.com - March 23 at 6:34 PM
electroCore, Inc. Announces Exclusive Distribution Agreement with Silvert Medical Nv-Sa. For Western Europe - GlobeNewswireelectroCore, Inc. Announces Exclusive Distribution Agreement with Silvert Medical Nv-Sa. For Western Europe - GlobeNewswire
globenewswire.com - March 23 at 8:33 AM
electroCore, Inc. Announces Exclusive Distribution Agreement with Silvert Medical Nv-Sa. For Western EuropeelectroCore, Inc. Announces Exclusive Distribution Agreement with Silvert Medical Nv-Sa. For Western Europe
finance.yahoo.com - March 23 at 8:33 AM
ECOR: More Distribution Agreements to ComeECOR: More Distribution Agreements to Come
finance.yahoo.com - March 22 at 12:25 PM
Chief Medical Officer of electroCore, Inc. Peter Staats, M.D. Describes Potential At-Home Solutions to Reduce Common COVID-19 Symptoms - Yahoo FinanceChief Medical Officer of electroCore, Inc. Peter Staats, M.D. Describes Potential At-Home Solutions to Reduce Common COVID-19 Symptoms - Yahoo Finance
finance.yahoo.com - March 15 at 2:10 PM
Chief Medical Officer of electroCore, Inc. Peter Staats, M.D. Describes Potential At-Home Solutions to Reduce Common COVID-19 Symptoms - Business WireChief Medical Officer of electroCore, Inc. Peter Staats, M.D. Describes Potential At-Home Solutions to Reduce Common COVID-19 Symptoms - Business Wire
businesswire.com - March 15 at 9:10 AM
Chief Medical Officer of electroCore, Inc. Peter Staats, M.D. Describes Potential At-Home Solutions to Reduce Common COVID-19 SymptomsChief Medical Officer of electroCore, Inc. Peter Staats, M.D. Describes Potential At-Home Solutions to Reduce Common COVID-19 Symptoms
finance.yahoo.com - March 15 at 9:10 AM
electroCores (ECOR) CEO Dan Goldberger on Q4 2020 Results - Earnings Call Transcript - Seeking AlphaelectroCore's (ECOR) CEO Dan Goldberger on Q4 2020 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - March 12 at 6:04 PM
electroCore Announces Fourth Quarter and Full Year 2020 Financial Results - GlobeNewswireelectroCore Announces Fourth Quarter and Full Year 2020 Financial Results - GlobeNewswire
globenewswire.com - March 11 at 10:38 PM
electroCore Announces Fourth Quarter and Full Year 2020 Financial Results - Yahoo FinanceelectroCore Announces Fourth Quarter and Full Year 2020 Financial Results - Yahoo Finance
finance.yahoo.com - March 11 at 5:38 PM
electroCore Announces Fourth Quarter and Full Year 2020 Financial ResultselectroCore Announces Fourth Quarter and Full Year 2020 Financial Results
finance.yahoo.com - March 11 at 5:38 PM
electroCore to Announce Fourth Quarter and Year Ended December 31, 2020 Financial Results on Thursday, March 11 - GlobeNewswireelectroCore to Announce Fourth Quarter and Year Ended December 31, 2020 Financial Results on Thursday, March 11 - GlobeNewswire
globenewswire.com - March 4 at 10:21 AM
electroCore to Announce Fourth Quarter and Year Ended December 31, 2020 Financial Results on Thursday, March 11electroCore to Announce Fourth Quarter and Year Ended December 31, 2020 Financial Results on Thursday, March 11
finance.yahoo.com - March 4 at 10:21 AM
electroCore to Participate at Two Upcoming Investor Conferences - GlobeNewswireelectroCore to Participate at Two Upcoming Investor Conferences - GlobeNewswire
globenewswire.com - March 3 at 6:59 PM
electroCore to Participate at Two Upcoming Investor ConferenceselectroCore to Participate at Two Upcoming Investor Conferences
finance.yahoo.com - March 3 at 6:59 PM
Electrocore Shares Rally: Some Technical Levels For The Medtech StockElectrocore Shares Rally: Some Technical Levels For The Medtech Stock
msn.com - March 3 at 8:58 AM
electroCore exclusive distribution deal Medistar after regulatory approval in Australia - Seeking AlphaelectroCore exclusive distribution deal Medistar after regulatory approval in Australia - Seeking Alpha
seekingalpha.com - March 1 at 5:51 PM
ElectroCore Announces GammaCore Sapphire NVNS Distribution Deal With MedistarElectroCore Announces GammaCore Sapphire NVNS Distribution Deal With Medistar
nasdaq.com - March 1 at 12:50 PM
ElectroCores Shares Are Trading Higher After Australia Okd Vagus Nerve Stimulator For HeadachesElectroCore's Shares Are Trading Higher After Australia Ok'd Vagus Nerve Stimulator For Headaches
finance.yahoo.com - March 1 at 12:50 PM
electroCore Inc. Announces Exclusive Distribution Agreement with Medistar Following Regulatory Approval in Australia - GlobeNewswireelectroCore Inc. Announces Exclusive Distribution Agreement with Medistar Following Regulatory Approval in Australia - GlobeNewswire
globenewswire.com - February 28 at 7:49 PM
electroCore Inc. Announces Exclusive Distribution Agreement with Medistar Following Regulatory Approval in AustraliaelectroCore Inc. Announces Exclusive Distribution Agreement with Medistar Following Regulatory Approval in Australia
finance.yahoo.com - February 28 at 7:49 PM
ElectroCore Concludes Enrollment In COVID-19 Study Evaluating Vagus Nerve Stimulation - BenzingaElectroCore Concludes Enrollment In COVID-19 Study Evaluating Vagus Nerve Stimulation - Benzinga
benzinga.com - February 24 at 6:55 PM
electroCore completes enrollment in - Seeking AlphaelectroCore completes enrollment in - Seeking Alpha
seekingalpha.com - February 24 at 1:55 PM
Non-Invasive Vagus Nerve Stimulation (nVNS) Enters New Stage of COVID-19 Research - Business WireNon-Invasive Vagus Nerve Stimulation (nVNS) Enters New Stage of COVID-19 Research - Business Wire
businesswire.com - February 24 at 8:54 AM
This page was last updated on 4/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.